These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7384333)

  • 1. Drug-related and illness-related factors in the outcome of chlorpromazine treatment: testing a model.
    Kolakowska T; Gelder MG; Orr MW
    Psychol Med; 1980 May; 10(2):335-43. PubMed ID: 7384333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study.
    Kolakowska T; Orr M; Gelder M; Heggie M; Wiles D; Franklin M
    Br J Psychiatry; 1979 Oct; 135():352-9. PubMed ID: 519119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment.
    Wiles DH; Kolakowska T; McNeilly AS; Mandelbrote BM; Gelder MG
    Psychol Med; 1976 Aug; 6(3):407-15. PubMed ID: 996201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential response to parenteral chlorpromazine and mesoridazine in psychotic patients.
    Brauzer B; Goldstein BJ
    J Clin Pharmacol J New Drugs; 1970; 10(2):126-31. PubMed ID: 4906541
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of sulpiride and chlorpromazine in psychoses. A double-blind multicentre study.
    Bratfos O; Haug JO
    Acta Psychiatr Scand; 1979 Jul; 60(1):1-9. PubMed ID: 382750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum prolactin levels in newly admitted psychiatric patients.
    Meltzer HY; Sachar EJ; Frantz AG
    Adv Biochem Psychopharmacol; 1974; 12(0):299-315. PubMed ID: 4422003
    [No Abstract]   [Full Text] [Related]  

  • 7. Lithium carbonate treatment in psychiatry.
    Sikes JC; Sikes SC
    Dis Nerv Syst; 1970 Jan; 31(1):52-5. PubMed ID: 5458977
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls.
    Meltzer HY; Busch DA; Creese IR; Snyder SH; Fang VS
    Psychiatry Res; 1981 Aug; 5(1):95-105. PubMed ID: 6944710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the drug treatment of the functional psychoses.
    Bennie FH
    Scott Med J; 1976 Apr; 21(2):79-82. PubMed ID: 941003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation.
    Kirkpatrick B; Buchanan RW; Maeda K; Carpenter WT; Jauch D; Tamminga CA
    Biol Psychiatry; 1989 Jun; 26(2):131-8. PubMed ID: 2567610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels.
    Rivera-Calimlim L; Nasrallah H; Strauss J; Lasagna L
    Am J Psychiatry; 1976 Jun; 133(6):646-52. PubMed ID: 5901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis.
    Phillipson OT; McKeown JM; Baker J; Healey AF
    Br J Psychiatry; 1977 Aug; 131():172-84. PubMed ID: 912219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine, serotonin and alpha-adrenergic receptor blocking activities in serum and their relationships to prolactin level in schizophrenic patients receiving long-term chlorpromazine treatment.
    Nakahara T; Hirano M; Uchimura H; Saito M; Kim JS; Matsumoto T; Yokoo H; Shimomura M; Mukai A
    Psychopharmacology (Berl); 1983; 79(2-3):266-70. PubMed ID: 6133307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oxyhemometric studies of patients with schizophrenia and reactive psychoses while treating them with neuroleptics].
    Timofeev NN; Kondrashenko VT; Nemtseva NIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(6):906-13. PubMed ID: 5723252
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
    Chouinard G; Annable L; Jones BD; Collu R
    Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction.
    Kolakowska T; Williams AO; Ardern M; Reveley MA; Jambor K; Gelder MG; Mandelbrote BM
    Br J Psychiatry; 1985 Mar; 146():229-39. PubMed ID: 2859067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acutely psychotic patients: a treatment approach.
    Wagemaker H; Lippmann S; Cade JR
    South Med J; 1985 Jul; 78(7):833-7. PubMed ID: 2861662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of chlorpromazine in serum by radioreceptor assay and HPLC.
    Krska J; Addison GM; Soni SD
    Ann Clin Biochem; 1986 May; 23 ( Pt 3)():340-5. PubMed ID: 3789642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium and chlorpromazine in psychotic inpatients.
    Braden W; Fink EB; Qualls CB; Ho CK; Samuels WO
    Psychiatry Res; 1982 Aug; 7(1):69-81. PubMed ID: 6813888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of response to neuroleptics in schizophrenia: clinical, pharmacologic, and neuroendocrine correlates.
    Gelder M; Kolakowska T
    Compr Psychiatry; 1979; 20(5):397-408. PubMed ID: 39704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.